Esther Bronchal-Ruiz
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Role of α-Synuclein in the Prefrontal Cortex: From Physiological Synaptic Modulation to Synaptic Failure in Parkinson's Disease.
Journal: Biomedicines
Published: May 20, 2026
Peripheral miRNA profiling identifies therapy-specific biological trajectories in the treatment of cognitive dysfunction in depression: an exploratory mechanistic study.
Journal: Scientific reports
Published: February 09, 2026
Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
Journal: International journal of molecular sciences
Published: January 10, 2022
Corrigendum to "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys" [EBioMedicine 2020; 59:102944].
Journal: EBioMedicine
Published: December 01, 2021
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.
Journal: Translational psychiatry
Published: July 26, 2021
mTOR Knockdown in the Infralimbic Cortex Evokes A Depressive-like State in Mouse.
Journal: International journal of molecular sciences
Published: July 14, 2021
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Journal: International journal of molecular sciences
Published: February 09, 2021
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.
Journal: EBioMedicine
Published: February 17, 2020
Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression.
Journal: Molecular neurobiology
Published: April 05, 2018
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 06, 2017
Last Updated: 09/26/2026